Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Celldex Therapeutics (CLDX) Q2 2023 Earnings
CLDX
4
May
Confirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-0.63
-0.59
-0.55
-0.51
Details
Expected EPS
-0.63
Actual EPS
-0.62
Surprise EPS
0.01
Surprise Percent
+1.59%
Description
Celldex Therapeutics (CLDX) has reported earnings of -0.62 per share for Q2 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login